Pharma giant Bayer is kicking off new digital collaboration efforts in the fields of cardiometabolic and renal disease, oncology and women’s health via a new initiative, dubbed the G4A Digital Health Partnership Program.
The program is split into two tracks, one for early-stage companies and another for more experienced companies. It tapped Caria, an AI and data company that matches people...
